200,000+ products from a single source!
sales@angenechem.com
180002-83-9 | Methanone, (2,3-dichlorophenyl)[5-methoxy-2-methyl-3-[2-(4-morpholinyl)ethyl]-1H-indol-1-yl]-
CAS No: 180002-83-9 Catalog No: AG0021L2 MDL No:
Product Description
Catalog Number:
AG0021L2
Chemical Name:
Methanone, (2,3-dichlorophenyl)[5-methoxy-2-methyl-3-[2-(4-morpholinyl)ethyl]-1H-indol-1-yl]-
CAS Number:
180002-83-9
Molecular Formula:
C23H24Cl2N2O3
Molecular Weight:
447.3543
IUPAC Name:
(2,3-dichlorophenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-ylethyl)indol-1-yl]methanone
InChI:
InChI=1S/C23H24Cl2N2O3/c1-15-17(8-9-26-10-12-30-13-11-26)19-14-16(29-2)6-7-21(19)27(15)23(28)18-4-3-5-20(24)22(18)25/h3-7,14H,8-13H2,1-2H3
InChI Key:
FSFZRNZSZYDVLI-UHFFFAOYSA-N
SMILES:
COc1ccc2c(c1)c(CCN1CCOCC1)c(n2C(=O)c1cccc(c1Cl)Cl)C
UNII:
85K154W99L
Properties
Complexity:
589
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
446.116g/mol
Formal Charge:
0
Heavy Atom Count:
30
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
447.356g/mol
Monoisotopic Mass:
446.116g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
43.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.1
Literature
| Title | Journal |
|---|---|
| Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. | Journal of medicinal chemistry 20131114 |
| Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives. | Bioorganic & medicinal chemistry 20110915 |
| Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging. | Bioorganic & medicinal chemistry 20110801 |
| Imidazopyridine CB2 agonists: optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy. | Bioorganic & medicinal chemistry letters 20110415 |
| Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. | Cell death & disease 20110401 |
| Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2. | European journal of medicinal chemistry 20110201 |
| Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain. | Osteoarthritis and cartilage 20101101 |
| Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy. | Neuropharmacology 20050401 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. | Pain 20020401 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.